Wealthspring Capital LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Wealthspring Capital LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$179,859
-90.7%
18,040
-90.8%
0.27%
-29.4%
Q3 2022$1,934,000
-1.5%
195,202
-2.6%
0.38%
+3.3%
Q2 2022$1,964,000
-5.0%
200,412
-5.0%
0.37%
-8.9%
Q1 2022$2,067,000
-10.8%
210,952
-8.8%
0.40%
-18.5%
Q4 2021$2,317,000
-7.5%
231,182
-7.7%
0.50%
-17.7%
Q3 2021$2,504,000
-10.1%
250,502
-9.6%
0.60%
-13.6%
Q2 2021$2,786,000
-3.7%
277,192
-5.5%
0.70%
-10.8%
Q1 2021$2,893,000293,4400.78%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,914,250,0003.01%
Wealthspring Capital LLC 277,192$2,786,0000.70%
BASSO CAPITAL MANAGEMENT, L.P. 135,404$1,361,0000.17%
Omni Partners US LLC 364,371$3,662,0000.16%
Sage Mountain Advisors LLC 93,470$939,0000.16%
Castle Creek Arbitrage, LLC 253,446$2,540,0000.14%
Shaolin Capital Management LLC 396,200$3,982,0000.12%
Context Capital Management, LLC 115,053$1,156,0000.11%
PERISCOPE CAPITAL INC. 250,000$2,512,0000.08%
Magnetar Financial LLC 803,400$8,074,0000.08%
View complete list of IBERE PHARMACEUTICALS shareholders